Stem cells have an innate property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life.
Mesenchymal stem cells have the ability to combat inflammation within the body. Once administered stem cells will try to repair tissue and reduce inflammation. This makes MSCs an attractive potential therapy for neuropathy and other conditions characterised by inflammation and/or tissue injury. Mesenchymal stem cells (MSCs) represent an attractive alternative to develop a cell-based therapy for RSD (Reflex Sympathetic Dystrophy).
Other potential advantages of stem cell therapy for people with RSD include their ability to move from the bloodstream to areas of injured tissues, allowing for a comfortable IV administration of these cells into the body. The stem cells will then be attracted to those areas of injury or inflammation and begin the process of differentiation to begin the healing process. Stem cell transplants for RSD are generally less invasive, have shorter recovery times, and lasting healing effects on the body.